Entering text into the input field will update the search result below

2 Buys and 1 Sell From Private Capital Management's Mutual Funds NUS

Jun. 22, 2011 5:25 PM ETNUS
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.
2 Buys and 1 Sell From Private Capital Management's Mutual Funds
Seeking Alpha June 22, 2011

Private Capital Management’s mutual funds have delivered a market-beating,
phenomenal 15.5% compound return over the last 24 years since the fund's inception.  The company manages $1.6 billion using a value investing philosophy, and with holdings across the capitalization spectrum. Two attractive buys from its portfolio include Motorola Mobility Holdings (MMI) and Nu Skin Enterprise (NUS).

Consumer non-cyclical sector: Buy Nu Skin Enterprise (NUS). 

PCM added a new position, its first in this sector, by buying a new $21 million
position in Nu Skin Enterprise, a network marketer of anti-aging personal care
products and nutritional supplements under the Nu Skin and Pharmanex brands.
Nu Skin is a baby boomer stock, and has been reporting phenomenal revenue and earnings growth every quarter. (18 consecutive quarters) The stock trades at a premium 15 forward P/E, but that is not so expensive given the strong growth and the promising outlook for the company’s products, and given the aging population in the U.S. and worldwide. Analyst targets are currently in the high-$30s, but as is the case with any such high growth company, one can expect these targets to keep getting raised as the company continues to beat numbers.

For complete story:  https://seekingalpha.com/article/276210-2-buys-and-1-sell-from-private-capital-management-s-mutual-funds?source=yahoo

Live With Intention,

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.